Master Alliance Provisions Guide (MAPGuide)

Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments

  • Term & termination | Term of agreement

<p><span style=”fontweight: 400;”>2. The release set forth in <a href=”” target=”_blankrel=”noopener“>Section 1a> above shall remain in effect with respect to a CLA Product for as long as a vaccine or medicine of that nature is in development or being commercialized under the CLA. For clarity, the release in Section 1 above shall terminate as to any vaccine or medicine for which GSK has terminated the development or commercialisation in accordance with the CLA.span>p>